Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy

Arun Kumar Singh has completed M. Pharm (Pharmaceutics) from Galgotias University, Greater Noida, India. Mr. Singh joined as an Assistant Professor in Amity Institute of Pharmacy, Amity University, Greater Noida. His area of interest is in the area of Nano-formulation, Blockchain, IoT, Machine learning, Cancer, Artificial intelligence, Big data and Neuroscience. He has authored one book with IOP publishing. He has published 5 chapters in the field of big data with prestigious River Publisher, Denmark. He has also published 24 review papers among which two are in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. His cumulative impact factor is 85.6. He has published 28 books with publishers such as Springer, IOP, Elsevier, CRC PRESS and Wiley. His strengths are research skills, thinking innovation, leadership qualities, decision-making, and positive thinking. His hard-working nature and devotion to his work make him distinguishable and extraordinary.

Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024.

Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.

Dr. Pranav Kumar Prabhakar is currently working as a Professor and Deputy Director at Parul University, Gujarat, India. He is one of the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, and 2024). He has completed his PhD in Biotechnology from IIT Madras. His main area of research interest focuses on elucidating molecular Mechanisms and Strategies for Oral Insulin Delivery, Mimicking the signaling pathways in Metabolic Disorders (diabetes) with Natural Products. He is a member of the Royal Society of Chemistry, and the Asia-Pacific Chemical, Biological& Environmental Engineering Society. He is also serving as an editorial board member and reviewer for many reputed national and International Journals. Dr. Pranav received honors including the recipient of a travel grant towards attending ATTD 2009 in Greece from the Indian Institute of Technology Madras & Council for Scientific and Industrial Research (CSIR) and approved by the Department of Science and Technology (DST). He has published 100+ research articles in journals, authored 8 books, and 25 book chapters. He also delivered 9 oral and poster presentations in scientific meetings.